Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current landscape and perspective of oncolytic viruses and their combination therapies
Yinghan Su, Changqing Su, Lun‐Xiu Qin
Translational Oncology (2022) Vol. 25, pp. 101530-101530
Open Access | Times Cited: 24

Showing 24 citing articles:

New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses
Anyeseu Park, Jeong Yoon Lee
The Journal of Microbiology (2024) Vol. 62, Iss. 7, pp. 491-509
Closed Access | Times Cited: 7
Oncolytic virus-based hepatocellular carcinoma treatment: Current status, intravenous delivery strategies, and emerging combination therapeutic solutions
Xinguo Li, Xiaonan Sun, Bingyuan Wang, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 18, Iss. 1, pp. 100771-100771
Open Access | Times Cited: 21
Engineering Microorganisms for Cancer Immunotherapy
Dingkang Liu, Lichao Yu, Haibo Rong, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 18
Closed Access | Times Cited: 3
Cancer immunotherapy and its facilitation by nanomedicine
Chao Sui, Heqing Wu, Xinxin Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Oncolytic virotherapy stimulates anti‑tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases
Yi-Ting Qiu, Aijun Qin, Jun Ding, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 2
Differential Replication and Oncolytic Effects of Zika Virus in Aggressive CNS Tumor Cells: Insights from Organoid and Tumoroid Models
Rodolfo Sanches Ferreira, Elisa Helena Farias Jandrey, Isabela Granha, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1764-1764
Open Access | Times Cited: 2
Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors
Bopei Cui, Lifang Song, Qian Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
Maryam Sadri, Alireza Najafi, Ali Rahimi, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110470-110470
Closed Access | Times Cited: 5
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
Targeting Clonal Mutations with Synthetic Microbes
Michael Renteln
(2024)
Open Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
Simultaneous Expression of Different Therapeutic Genes by Infection with Multiple Oncolytic HSV-1 Vectors
Adriana Vitiello, Alberto Reale, Valeria Conciatori, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1577-1577
Open Access | Times Cited: 1
Targeting Clonal Mutations with Synthetic Microbes
Michael Renteln
(2024)
Open Access | Times Cited: 1
HSV: The scout and assault for digestive system tumors
Sheng Li, Qingbo Li, Yi Ren, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
A promising future in cancer immunotherapy: Oncolytic viruses
Seyed Mahmood Seyed Khorrami, Arezou Azadi, Nasrin Rastegarvand, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176063-176063
Closed Access | Times Cited: 3
Development, optimization, and scale‐up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus‐1
Chun Fang Shen, Elodie Burney, Rénald Gilbert, et al.
Biotechnology Journal (2023) Vol. 19, Iss. 1
Closed Access | Times Cited: 2
Molecular insights and promise of oncolytic virus based immunotherapy
Mahalaxmi Iyer, Nandita Ravichandran, Panimalar Abirami Karuppusamy, et al.
Advances in protein chemistry and structural biology (2024), pp. 419-492
Closed Access
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access
Progression of oncolytic virus in liver cancer treatment
Xuesi Hua, Siyu Xuan, Yangyang Tang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Clinical and Translational Landscape of Viral Gene Therapies
Alexandra Yudaeva, Anastasiya Kostyusheva, Artyom Kachanov, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1916-1916
Open Access
Exploring the genetic associations and causal relationships between antibody responses, immune cells, and various types of breast cancer
Yang Yang, Jiayi Chen, Fuhong Gong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Targeting clonal mutations with synthetic microbes
Michael Renteln
Critical Reviews in Oncology/Hematology (2024), pp. 104572-104572
Closed Access
Page 1

Scroll to top